(Q52166777)

26 April 2018

title

Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats. (English)

1 reference

26 April 2018

author name string

Takahashi S

series ordinal

1

1 reference

26 April 2018

Miwa T

series ordinal

2

1 reference

26 April 2018

Horikomi K

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

26 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

26 April 2018

volume

289

1 reference

26 April 2018

issue

1

1 reference

26 April 2018

page(s)

21-24

1 reference

26 April 2018

Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

The substantia nigra and stereotyped behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

BMY 14802, a sigma receptor ligand for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Repeated methamphetamine-treatment alters brain sigma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Chronic amphetamine: Is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

sigma Receptor antagonists block the development of sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

Supersensitivity of sigma receptors after repeated administration of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901258-1

7 January 2021

10.1016/S0304-3940(00)01258-1

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

10899399

1 reference

26 April 2018